Thyroid C-mobile Tumors: In rodent studies, semaglutide has long been revealed to result in thyroid C-mobile tumors. It is not known no matter if this possibility applies to humans, but semaglutide is contraindicated in patients with a private or family historical past of medullary thyroid carcinoma (MTC) or clients with Multiple Endocrine Neoplasi